Successful Treatment of Steroid-refractory COVID-19-associated Organizing Pneumonia With Intravenous Immunoglobulin (IVIG)

Research output: Contribution to conference › Abstract › peer-review

Original language	English (US)
DOIs	https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1463
State	Published - May 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@conference{afdf20d260b04cc0bfc527b1728e0e9d,

title = "Successful Treatment of Steroid-refractory COVID-19-associated Organizing Pneumonia With Intravenous Immunoglobulin (IVIG)",

author = "A. Jbeli and L. Bolden and H.H. Desai and B. Akpa",

year = "2023",

month = may,

doi = "10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1463",

language = "English (US)",

}

TY - CONF

T1 - Successful Treatment of Steroid-refractory COVID-19-associated Organizing Pneumonia With Intravenous Immunoglobulin (IVIG)

AU - Jbeli, A.

AU - Bolden, L.

AU - Desai, H.H.

AU - Akpa, B.

PY - 2023/5

Y1 - 2023/5

UR - http://dx.doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1463

U2 - 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1463

DO - 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a1463

M3 - Abstract

ER -